An official website of the United States government
153rd Meeting of the National Advisory Council on Drug Abuse
Hybrid Meeting: Tuesday, May 5, 2026
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.
C. Appendix 2).
| Time | Presentation |
|---|---|
| 10:30 a.m. | Call to Order Nora Volkow, M.D. Director, NIDA Review of Policy and Procedures Susan Weiss, Ph.D. Executive Secretary National Advisory Council on Drug Abuse Director, Division of Extramural Research, NIDA |
| 10:45 a.m. | Council Review of Grant Applications Nora Volkow, M.D., Director, NIDAOffice of Research Training and Career Development (ORTCD) Wilson Compton, M.D., M.P.E. Deputy Director, NIDAOffice of Translational Initiatives and Program Innovations (OTIPI) Elena Koustova, Ph.D., M.B.A. DirectorDivision of Therapeutics and Medical Consequences (DTMC) Iván Montoya, M.D., M.P.H. DirectorDivision of Neuroscience and Behavior (DNB) Tristan McClure-Begley, Ph.D. Acting DirectorDivision of Epidemiology, Services, and Prevention Research (DESPR) Carlos Blanco, M.D., Ph.D. Director |
| 11:45 a.m. | Board of Scientific Counselors (BSC) Update Lorenzo Leggio, M.D., Ph.D. Clinical Director, IRP Rodrigo España, Ph.D. BSC Acting Chair |
| 12:15 p.m. | Break |
Videocast:
Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Gillian Acca , within ten days of the meeting. Any written statements by members of the public will receive careful consideration.
Join the Videocast .
Open to the Public
| Time | Presentation |
|---|---|
| 1:30 p.m. | Welcome and Opening Remarks Nora Volkow, M.D. Director, NIDA |
| 1:45 p.m. | Director's Report Nora Volkow, M.D. Director, NIDA |
| 2:15 p.m. | Discussion Council Members |
| 2:45 p.m. | Break |
| 3:00 p.m. | NIDA 2027-2031 Strategic Plan Update Daniel Stimson, J.D., Ph.D. Health Science Policy Analyst, Office of Scientific Planning and Coordination (OSPC) |
| 3:30 p.m. | Division of Neuroscience and Behavior (DNB) Prospectus 2026 and Beyond: Evolving Core Topics to Bridge Mechanistic Gaps Tristan McClure-Begley, Ph.D. Acting Director, DNB |
| 4:00 p.m. | Public Comments |
| 4:15 p.m. | Adjourn |